Patent Assignment
Reel/Frame 070083/0887
Merger
Recorded: 2025-02-03
Pages: 5
Assignor
VALO EARLY DISCOVERY, INC.
Executed: 2021-09-01
Assignee
VALO HEALTH, INC.
75 HAYDEN AVENUE, SUITE 200, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Inhibiting Deubiquitinase USP25 and USP28
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Sep 8, 2021
From: VALO EARLY DISCOVERY, INC.
To: VALO HEALTH, INC.
Reel/Frame 057438/0025 →
Release of Security Interest
Oct 17, 2023
From: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
To: VALO HEALTH, INC.; VALO HEALTH, LLC
Reel/Frame 065255/0660 →
Assignment of Assignor's Interest
Dec 2, 2024
From: GUERIN, DAVID J.; CARAVELLA, JUSTIN A.; LI, HONGBIN; MISCHKE, STEVEN
To: FORMA THERAPEUTICS, INC.
Reel/Frame 069453/0509 →
Assignment of Assignor's Interest
Jan 10, 2025
From: FORMA THERAPEUTICS, INC.
To: INTEGRAL EARLY DISCOVERY, INC.
Reel/Frame 069871/0201 →
Change of Name
Jan 24, 2025
From: INTEGRAL EARLY DISCOVERY, INC.
To: VALO EARLY DISCOVERY, INC.
Reel/Frame 070005/0521 →